Lexapro

Lundbeck faces sharp fall in growth from 2009 as Asian Lexapro patent ...
Posted by Lexapro (Lexapro) on Tue, 11 Sep 2007 23:16:50 +0000

Forbes - COPENHAGEN (Thomson Financial) - H Lundbeck AS faces a sharp fall in growth from 2009, when the patent on its depression treatment Lexapro expires in important Asian markets, daily Boersen said, citing Morten Bryde Hansen, regional director for Asia ...

Danish shares higher midmorning; shipping stocks, Vestas higher in ...
Forbes - Investors are ignoring a report in daily Boersen saying the group faces a sharp fall in growth from 2009, when the Asian patent on its depression treatment Lexapro expires. Novo Nordisk rose 8 to 613. The group ranks as best-in-class in healthcare ...

Danish shares TFN at a glance outlook
CNBC - ... TODAY'S PRESS -Scottish & Newcastle either very critical of possible acquisition by Carlsberg, or are talking the price up analysts (Boersen) -Lundbeck faces sharp fall in growth from 2009, when Asian patent on depression treatment Lexapro ...

Teva Spending Plenty of Time in Court
Motley Fool - Last Wednesday, Teva lost another court case -- this time with Forest Laboratories (NYSE: FRX ) over patents surrounding its antidepressant Lexapro. An appeals court upheld a lower court's ruling from July of 2006 supporting Forest's patents. Teva has ...

Shrink's Progress
American Reporter - For example, of all of the antidepressants of the SSRI family, Celexa and its cousin, Lexapro, have a much lower incidence of sexual dysfunction than Paxil, Luvox, Prozac or Zoloft. In the SNRI family one might switch from Effexor to Cymbalta. A ...